These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32271170)

  • 1. Pancreatic tropism of metastatic renal cell carcinoma.
    Singla N; Xie Z; Zhang Z; Gao M; Yousuf Q; Onabolu O; McKenzie T; Tcheuyap VT; Ma Y; Choi J; McKay R; Christie A; Torras OR; Bowman IA; Margulis V; Pedrosa I; Przybycin C; Wang T; Kapur P; Rini B; Brugarolas J
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.
    Eckel-Passow JE; Serie DJ; Cheville JC; Ho TH; Kapur P; Brugarolas J; Thompson RH; Leibovich BC; Kwon ED; Joseph RW; Parker AS
    BMC Urol; 2017 Mar; 17(1):19. PubMed ID: 28327121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
    Massari F; Ciccarese C; Bria E; Porta C; La Russa F; Knuutila S; Artibani W; Porcaro AB; Bimbatti D; Modena A; Sava T; Tortora G; Cheng L; Eccher A; Cima L; Pedron S; Ghimenton C; Martignoni G; Brunelli M
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):39-43. PubMed ID: 26509904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma.
    da Costa WH; Fares AF; Bezerra SM; Morini MA; de Toledo Benigno LA; Clavijo DA; Fornazieri L; Rocha MM; da Cunha IW; de Cassio Zequi S
    Urol Oncol; 2019 Jan; 37(1):78-85. PubMed ID: 30446457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma.
    Wen YC; Lin YW; Chu CY; Yang YC; Yang SF; Liu YF; Hsiao M; Lee WJ; Chien MH
    J Pineal Res; 2020 Sep; 69(2):e12668. PubMed ID: 32408377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
    Köhn L; Svenson U; Ljungberg B; Roos G
    Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
    Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
    Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Sun G; Zhang X; Liang J; Pan X; Zhu S; Liu Z; Armstrong CM; Chen J; Lin W; Liao B; Lin T; Huang R; Zhang M; Zheng L; Yin X; Nie L; Shen P; Zhao J; Zhang H; Dai J; Shen Y; Li Z; Liu J; Chen J; Liu J; Wang Z; Zhu X; Ni Y; Qin D; Yang L; Chen Y; Wei Q; Li X; Zhou Q; Huang H; Yao J; Chen N; Zeng H
    Clin Cancer Res; 2021 Mar; 27(6):1734-1743. PubMed ID: 33414138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
    Shin TJ; Song C; Jeong CW; Kwak C; Seo S; Kang M; Chung J; Hong SH; Hwang EC; Park JY; Lee H
    J Surg Oncol; 2021 Jan; 123(1):204-213. PubMed ID: 33047324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 loss defines a new class of renal cell carcinoma.
    Peña-Llopis S; Vega-Rubín-de-Celis S; Liao A; Leng N; Pavía-Jiménez A; Wang S; Yamasaki T; Zhrebker L; Sivanand S; Spence P; Kinch L; Hambuch T; Jain S; Lotan Y; Margulis V; Sagalowsky AI; Summerour PB; Kabbani W; Wong SW; Grishin N; Laurent M; Xie XJ; Haudenschild CD; Ross MT; Bentley DR; Kapur P; Brugarolas J
    Nat Genet; 2012 Jun; 44(7):751-9. PubMed ID: 22683710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.
    Hakimi AA; Ostrovnaya I; Reva B; Schultz N; Chen YB; Gonen M; Liu H; Takeda S; Voss MH; Tickoo SK; Reuter VE; Russo P; Cheng EH; Sander C; Motzer RJ; Hsieh JJ;
    Clin Cancer Res; 2013 Jun; 19(12):3259-67. PubMed ID: 23620406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis.
    Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
    Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.
    Liu XD; Kong W; Peterson CB; McGrail DJ; Hoang A; Zhang X; Lam T; Pilie PG; Zhu H; Beckermann KE; Haake SM; Isgandrova S; Martinez-Moczygemba M; Sahni N; Tannir NM; Lin SY; Rathmell WK; Jonasch E
    Nat Commun; 2020 May; 11(1):2135. PubMed ID: 32358509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion.
    Qiu J; Fu Y; Liu T; Wang J; Liu Y; Zhang Z; Ye Z; Cao Z; Su D; Luo W; Tao J; Weng G; Ye L; Zhang F; Liang Z; Zhang T
    Cancer Lett; 2024 Oct; 601():217193. PubMed ID: 39159881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.
    Sellner F; Compérat E; Klimpfinger M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of host immunity on metastatic potential in renal cell carcinoma: the assessment of optimal in vivo models to study metastatic behavior of renal cancer cells.
    Kobayashi M; Morita T; Chun NA; Matsui A; Takahashi M; Murakami T
    Tumour Biol; 2012 Apr; 33(2):551-9. PubMed ID: 22219032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.